Discontinued — last reported Q2 '19

Current Assets

Available-for-Sale Debt Securities - Unrealized Loss Position (<12 Months)

Medtronic Available-for-Sale Debt Securities - Unrealized Loss Position (<12 Months) decreased by 1.4% to $749.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 12.1%, from $852.00M to $749.00M. Over 4 years (FY 2021 to FY 2025), Available-for-Sale Debt Securities - Unrealized Loss Position (<12 Months) shows a downward trend with a -3.7% CAGR. This is a positive signal — lower values indicate better performance for this metric.

Analysis

StatementBalance Sheet Statement
SectionCurrent Assets
CategoryRisk
SignalLower is better
VolatilityModerate
First reportedQ3 2017
Last reportedQ2 2019

How to read this metric

An increase often signals rising interest rates or short-term market stress affecting the bond portfolio.

Detailed definition

This metric tracks the unrealized losses on available-for-sale debt securities that have been in a loss position for les...

Peer comparison

Commonly monitored by investors to assess interest rate sensitivity.

Metric ID: afs_debt_securities_unrealized_loss_less_than_12m

Historical Data

19 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25
Value$976.00M$0.00$0.00$222.00M$243.00M$207.00M$292.00M$401.00M$488.00M$528.00M$600.00M$838.00M$803.00M$782.00M$852.00M$814.00M$735.00M$760.00M$749.00M
QoQ Change—-100.0%——+9.5%-14.8%+41.1%+37.3%+21.7%+8.2%+13.6%+39.7%-4.2%-2.6%+9.0%-4.5%-9.7%+3.4%-1.4%
YoY Change————-75.1%——+80.6%+100.8%+155.1%+105.5%+109.0%+64.5%+48.1%+42.0%-2.9%-8.5%-2.8%-12.1%
Range$0.00 – $976.00M
CAGR-5.7%
Avg YoY Growth+46.5%
Median YoY Growth+48.1%

Frequently Asked Questions

What is Medtronic's available-for-sale debt securities - unrealized loss position (<12 months)?
Medtronic (MDT) reported available-for-sale debt securities - unrealized loss position (<12 months) of $749.00M in Q4 2025.
How has Medtronic's available-for-sale debt securities - unrealized loss position (<12 months) changed year-over-year?
Medtronic's available-for-sale debt securities - unrealized loss position (<12 months) decreased by 12.1% year-over-year, from $852.00M to $749.00M.
What is the long-term trend for Medtronic's available-for-sale debt securities - unrealized loss position (<12 months)?
Over 4 years (2021 to 2025), Medtronic's available-for-sale debt securities - unrealized loss position (<12 months) has grown at a -3.7% compound annual growth rate (CAGR), from $946.00M to $814.00M.
What does available-for-sale debt securities - unrealized loss position (<12 months) mean?
Unrealized losses on debt investments held for sale that have been losing value for less than a year.